Sale

Smart Inhalers Market

Global Smart Inhalers Market Size, Share, Analysis, Trends: By Product Type: Dry Powder Inhaler (DPI), Metered Dose Inhalers (MDIs); By Application: Asthma, COPD, Others; By End User: Hospitals, Clinics, Home Settings, Others; By Distribution Channel: Hospital Pharmacies, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Smart Inhalers Market Outlook

The global smart inhalers market size attained a value of USD 0.78 billion in 2023, driven by the growing geriatric population worldwide, increasing preference towards smart and effective inhalers. The market is forecasted to grow at a CAGR of 17.1% during the forecast period of 2024-2032 to achieve a value of USD 3.25 billion by 2032.

 

Global Smart Inhalers Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Smart inhalers are referred to as the devices that enable the delivery of a variety of medication via inhalation. They are termed as smart due to sensors that are attached to the inhalers monitoring the correct dose per intake as well as the technique used while inhaling the medication.

The smart inhalers market is segmented based on products, indications, and distribution channels.

 

Global Smart Inhalers Market By Indication

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

On the basis of products, the smart inhalers market is divided into:

  • Inhalers
    • Dry Powder Inhalers
    • Metered Dose Inhalers
  • Nebulizers

Based on indication, the smart inhalers market is segmented into:

  • Asthma
  • COPD

On the basis of distribution channels, the smart inhalers market is divided into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The EMR report looks into the regional smart inhalers markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Smart Inhalers Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global smart inhalers market is driven by the smart and effective manner to inhale the medicine, as compared to the usual inhalers. Recent developments in the manufacturing of smart inhalers, as well as devices having built-in smart inhalers, are expected to aid the smart inhalers market growth. The rise in the prevalence of people who have asthma and chronic obstructive pulmonary diseases is expected to enhance the market growth.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global smart inhalers market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Adherium Limited 
  • AstraZeneca PLC 
  • Boehringer Ingelheim International GmbH
  • Cohero Health, Inc. 
  • GlaxoSmithKline plc 
  • Teva Pharmaceutical Industries Limited
  • Vectura Group plc
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Application
  • End User
  • Distribution Channel
  • Region
Breakup by Product Type
  • Dry Powder Inhaler (DPI)
  • Metered Dose Inhalers (MDIs)
Breakup by Application
  • Asthma
  • COPD
  • Others
Breakup by End User
  • Hospitals
  • Clinics
  • Home Settings
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Adherium Limited
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Cohero Health, Inc.
  • GlaxoSmithKline plc.
  • Teva Pharmaceutical Industries Limited
  • Vectura Group plc
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Smart Inhalers Market Overview 

    3.1    Global Smart Inhalers Market Historical Value (2017-2023) 
    3.2    Global Smart Inhalers Market Forecast Value (2024-2032)
4    Global Smart Inhalers Market Landscape
    4.1    Global Smart Inhalers Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Smart Inhalers Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Indication Type
        4.2.3    Analysis by End User
5    Global Smart Inhalers Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Smart Inhalers Market Segmentation 
    6.1    Global Smart Inhalers Market by Product Type                                                                                         
        6.1.1    Market Overview
        6.1.2    Dry Powder Inhaler (DPI) 
        6.1.3    Metered Dose Inhalers (MDIs)
    6.2    Global Smart Inhalers Market by Application                                                                                          
        6.2.1    Market Overview
        6.2.2    Asthma
        6.2.3    COPD
        6.2.4    Others
    6.3    Global Smart Inhalers Market by End User
        6.3.1    Market Overview
        6.3.2    Hospitals
        6.3.3    Clinics
        6.3.4    Home Settings
        6.3.5    Others
    6.4    Global Smart Inhalers Market by Distribution Channel                                                                                            
        6.4.1    Market Overview
        6.4.2    Hospital Pharmacies
        6.4.3    Retail Pharmacies
        6.4.4    Online Pharmacies
    6.5    Global Smart Inhalers Market by Region
        6.5.1    Market Overview
        6.5.2    North America 
        6.5.3    Europe
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Smart Inhalers Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Smart Inhalers Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Smart Inhalers Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Smart Inhalers Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Smart Inhalers Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Adherium Limited
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    AstraZeneca PLC
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Boehringer Ingelheim International GmbH
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Cohero Health, Inc. 
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    GlaxoSmithKline plc.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Teva Pharmaceutical Industries Limited
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Vectura Group plc
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
18    Global Smart Inhalers Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The global market for smart inhalers reached a value of USD 0.78 billion in 2023.

The market is projected to expand at a CAGR of 17.1% from 2024 to 2032, growing to USD 3.25 billion by 2032.

The industry is driven by the growing geriatric population worldwide, increasing preference towards smart and effective inhalers, the growing investments in the medical sector, and the growing innovations in the manufacturing of smart inhalers.

The key trend propelling the industry growth include the growing incidences of asthma and chronic obstructive pulmonary disease (COPD) worldwide.

The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

The significant products include inhalers and nebulisers.

The major segments based on indication include asthma and COPD.

The significant distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.

The major players in the industry are Adherium Limited, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cohero Health, Inc., Teva Pharmaceutical Industries Limited, GlaxoSmithKline plc, Vectura Group plc, and others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER